Personalis reported record revenues of $18.2 million in the fourth quarter of 2019, a 38% increase compared to the same period in the prior year. The growth was primarily driven by an increase in volume for testing and analytical services provided to the U.S. Department of Veterans Affairs Million Veteran Program (VA MVP).
Reported record revenues of $18.2 million in Q4 2019, a 38% increase year-over-year.
A total of 9 different customers placed orders for NeXT during Q4 2019.
Launched NeXT Dx Test, a diagnostic test for biopharmaceutical customers to utilize in clinical trials.
VA MVP accounted for 76% of revenues in Q4 2019.
Due to uncertainty surrounding the COVID-19 pandemic, Personalis is withdrawing previous 2020 guidance and will provide an updated outlook for 2020 during its first quarter earnings announcement and press release.
Analyze how earnings announcements historically affect stock price performance